LEF-1 is a decisive transcription factor in neutrophil granulopoiesis

Annals of the New York Academy of Sciences

Volumn 1106, Issue , 2007, Pages 143-151

  Skokowa, Julia ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C EBP ; ELA2; HAX1; LEF 1; Severe congenital neutropenia

Indexed keywords

CYCLIN D1; ELASTASE; ELASTASE II; LEUKOCYTE ELASTASE; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN ALPHA; HAX1 PROTEIN, HUMAN; LEF1 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN;

BINDING AFFINITY; CELL LINEAGE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GRANULOCYTE; GRANULOPOIESIS; HUMAN; HUMAN CELL; LYMPHOPOIESIS; MYELOID PROGENITOR CELL; NEUTROPENIA; NEUTROPHIL; PROMOTER REGION; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; REVIEW; SYNDROME;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; GRANULOCYTES; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MODELS, BIOLOGICAL; MUTATION; NEUTROPENIA; NEUTROPHILS; PROTEINS; RNA, MESSENGER; SYNDROME; TRANSCRIPTION FACTORS;

EID: 34548416774     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1392.012     Document Type: Conference Paper

References (36)

1. SKOKOWA, J., G. CARIO, M. UENALAN, et al. 2006. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat. Med. 12: 1191-1197.
2. CLEVERS, H. & M. VAN DE WETERING. 1997. TCF/LEF factor earn their wings. Trends Genet. 13: 485-489.
3. ARCE, L., N.N. YOKOYAMA & M.L. WATERMAN. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25: 7492-7504.
4. NOVAK, A. & S. DEDHAR.1999. Signaling through beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56: 523-537.
5. NAWSHAD, A. & E.D. HAY. 2003. TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J. Cell. Biol. 163: 1291-1301.
6. ROSS, D.A. & T. KADESCH. 2001. The notch intracellular domain can function as a coactivator for LEF-1. Mol. Cell. Biol. 21: 7537-7544.
7. LOVE, J.J., X. LI, D.A. CASE, et al. 1995. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791-795.
8. GIESE, K., C. KINGSLEY, J.R. KIRSHNER, et al. 1995. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9: 995-1008.
9. BRUHN, L., A. MUNNERLYN & R. GROSSCHEDL. 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev. 11: 640-653.
10. JIN, Z.X., H. KISHI, X.C. WEI, et al. 2002. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells. J. Immunol. 169: 3783-3792.
11. REYA, T., M. O'RIORDAN, R. OKAMURA, et al. 2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13: 15-24.
12. WILLINGER, T., T. FREEMAN, M. HERBERT, et al. 2006. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J. Immunol. 176: 1439-1446.
13. DOSEN, G., E. TENSTAD, M.K. NYGREN, et al. 2006. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol. 7: 13.
14. WELTE, K., C. ZEIDLER, D.C. DALE. 2006. Severe congenital neutropenia. Semin. Hematol. 43: 189-195.
15. SKOKOWA, J., M. GERMESHAUSEN, C. ZEIDLER, et al. 2007. Severe congenital neutropenia: inheritance and pathophysiology. Curr. Opin. Hematol. 14: 22-28.
16. HORWITZ, M., K.F. BENSON, R.E. PERSON, et al. 1999. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoesis. Nat. Genet. 23: 433-436.
17. KLEIN, C., M. GRUDZIEN, G. APPASWAMY, et al. 2007. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39: 86-92.
18. DALE, D.C., R.E. PERSON, A.A. BOLYARD, et al. 2000. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317-2322.
19. THUSBERG, J., & M. VIHINEN. 2006. Bioinformatic analysis of protein structurefunction relationships: case study of leukocyte elastase (ELA2) missense mutations. Hum. Mutat. 27: 1230-1243.
20. GRENDA, D.S., S.E. JOHNSON, J.R. MAYER, et al. 2002. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood 100: 3221-3228.
21. MASSULLO, P., L.J. DRUHAN, B.A. BUNNELL, et al. 2005. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 105: 3397-3404.
22. APRIKYAN, A.A., T. KUTYAVIN, S. STEIN, et al. 2003. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp. Hematol. 31: 372-381.
23. KÖLLNER, I., B. SODEIK, S. SCHREEK, et al. 2006. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108: 493-500.
24. KONISHI, N., M. KOBAYASHI, S. MIYAGAWA, et al. 1999. Defective proliferation of primitivemyeloid progenitor cells in patients with severe congenital neutropenia. Blood 94: 4077-4083.
25. CARIO, G., J. SKOKOWA, Z. WANG, et al. 2005. Heterogeneous expression pattern of pro- and anti-apoptotic factors inmyeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br. J. Haematol. 129: 275-278.
26. SERA, Y., H. KAWAGUCHI, K. NAKAMURA, et al. 2005. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 90: 1032-1041.
27. LI, F.Q., R.E. PERSON, K. TAKEMARU, et al. 2004. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2. J. Biol. Chem. 279: 2873-2884.
28. OELGESCHLAGER, M., I. NUCHPRAYOON, B. LUSCHER, et al. 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16: 4717-4725.
29. LAUSEN, J., S. LIU, M. FLIEGAUF, et al. 2006. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25: 1349-1357.
30. WANG, W., X. WANG, A.C. WARD, et al. 2001. C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia. 15: 779-786.
31. MEMPEL, K., T. PIETSCH, T. MENZEL, et al. 1991. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood. 77: 1919-1922.
32. KYAS, U., T. PIETSCH, K. WELTE. 1992. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. Blood. 79: 1144-1147.
33. NAKAMURA, K., M. KOBAYASHI, N. KONISHI, et al. 2002. Defects of granulopoiesis in patients with severe congenital neutropenia. Hiroshima J. Med. Sci. 51: 63-74.
34. JAMIESON, C.H., L.E. AILLES, S.J. DYLLA, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351: 657-667.
35. SCHELLER, M., J. HUELSKEN, F. ROSENBAUER, et al. 2006. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat. Immunol. 7: 1037-1047.
36. MERRILL, B.J., U. GAT, R. DASGUPTA, et al. 2001. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 15: 1688-1705.